These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29553311)

  • 1. Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence.
    MacIntyre CR; Costantino V; Chen X; Segelov E; Chughtai AA; Kelleher A; Kunasekaran M; Lane JM
    Emerg Infect Dis; 2018 Apr; 24(4):646-653. PubMed ID: 29553311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological Immunity to Smallpox in New South Wales, Australia.
    Costantino V; Trent MJ; Sullivan JS; Kunasekaran MP; Gray R; MacIntyre R
    Viruses; 2020 May; 12(5):. PubMed ID: 32443405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling of optimal vaccination strategies in response to a bioterrorism associated smallpox outbreak.
    Costantino V; Kunasekaran M; MacIntyre CR
    Hum Vaccin Immunother; 2021 Mar; 17(3):738-746. PubMed ID: 33734944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
    Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
    MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of historical data suggests long-lasting protective effects of smallpox vaccination.
    Eichner M
    Am J Epidemiol; 2003 Oct; 158(8):717-23. PubMed ID: 14561660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expected adverse events in a mass smallpox vaccination campaign.
    Kemper AR; Davis MM; Freed GL
    Eff Clin Pract; 2002; 5(2):84-90. PubMed ID: 11990216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome.
    Bartlett JG
    Clin Infect Dis; 2003 Feb; 36(4):468-71. PubMed ID: 12567305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the duration of vaccine-induced residual protection against severe and fatal smallpox based on secondary vaccination failure.
    Nishiura H; Eichner M
    Infection; 2006 Oct; 34(5):241-6. PubMed ID: 17033746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Containing bioterrorist smallpox.
    Halloran ME; Longini IM; Nizam A; Yang Y
    Science; 2002 Nov; 298(5597):1428-32. PubMed ID: 12434061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
    Handley L; Buller RM; Frey SE; Bellone C; Parker S
    Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
    Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical guidance for smallpox vaccine use in a postevent vaccination program.
    Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE
    MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of immunity after smallpox vaccination: a study on vaccination policy against smallpox bioterrorism in Japan.
    Arita I
    Jpn J Infect Dis; 2002 Aug; 55(4):112-6. PubMed ID: 12403907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination-Related Side Effects, Humoral Immunity, and Adverse Events during the Civilian Smallpox Vaccination Campaign, Arkansas, 2003.
    Haselow D
    Public Health Nurs; 2016; 33(2):129-38. PubMed ID: 26043870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US Civilian Smallpox Preparedness and Response Program, 2003.
    Strikas RA; Neff LJ; Rotz L; Cono J; Knutson D; Henderson J; Orenstein WA
    Clin Infect Dis; 2008 Mar; 46 Suppl 3():S157-67. PubMed ID: 18284355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smallpox eradication in Brazil, 1967-69.
    de Carvalho Filho ES; Morris L; de Lemos AL; Ponce de Leon J; Escobar A; da Silva OJ
    Bull World Health Organ; 1970; 43(6):797-807. PubMed ID: 5314627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Smallpx vaccination].
    Just M
    Schweiz Med Wochenschr; 1968 Mar; 98(13):495-503. PubMed ID: 5700509
    [No Abstract]   [Full Text] [Related]  

  • 20. [Danger to the human caused by animal poxvirus following discontinuation of mandatory vaccination against smallpox].
    Mayr A
    Hautarzt; 1985 Sep; 36(9):493-5. PubMed ID: 2999033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.